|
|
||||||||
1 Division of Pediatric Surgery and Developmental Biology Program, Childrens Hospital Los Angeles Research Institute, Keck School of Medicine, University of Southern California, Los Angeles 90027; 2 The Center for Craniofacial Molecular Biology, University of Southern California School of Dentistry, Los Angeles, California 90033; 3 Equipe Morphogénèse Cellulaire et Progression Tumorale, Institut Curie Unité Mixte de Recherche 144 Centre National de la Recherche Scientifique, 75005 Paris; 4 Service de Pédiatrie et Réanimation Néonatales-UPRES EA2704, Hôpital Antoine Béclère, 92141 Clamart; 5 Service de Physiologie Respiratoire, Hôpital Cochin, Université René Descartes, 75005 Paris; 6 Vascular Biology Research Group, University of Alberta, Edmonton, Alberta T6G 2S2, Canada; and 7 Institut National de la Santé et de la Recherche Médicale Unité 319, Universite Jussieu, 75005 Paris, France
We evaluated the role of the key pulmonary morphogenetic gene fibroblast growth factor-10 (Fgf10) in murine nitrofen-induced primary lung hypoplasia, which is evident before the time of diaphragm closure. In situ hybridization and competitive RT-PCR revealed a profound disturbance in the temporospatial pattern as well as a 10-fold decrease in mRNA expression level of Fgf10 but not of the inducible inhibitor murine Sprouty2 (mSpry2) after nitrofen treatment. Exogenous FGF-10 increased branching not only of control lungs [13% (right) and 27% (left); P < 0.01] but also of nitrofen-exposed lungs [23% (right) and 77% (left); P < 0.01]. Expression of mSpry2 increased 10-fold with FGF-10 in both nitrofen-treated and control lungs, indicating intact downstream FGF signaling mechanisms after nitrofen treatment. We conclude that nitrofen inhibits Fgf10 expression, which is essential for lung growth and branching. Exogenous FGF-10 not only stimulates FGF signaling, marked by increased mSpry2 expression, in both nitrofen-treated and control lungs but also substantially rescues nitrofen-induced lung hypoplasia in culture.
congenital diaphragmatic hernia; lung hypoplasia; fibroblast growth factor-10; murine Sprouty2
This article has been cited by other articles:
![]() |
M. J. Mondrinos, S. Koutzaki, P. I. Lelkes, and C. M. Finck A tissue-engineered model of fetal distal lung tissue Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L639 - L650. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Featherstone, M. G. Connell, D. G. Fernig, S. Wray, T. V. Burdyga, P. D. Losty, and E. C. Jesudason Airway Smooth Muscle Dysfunction Precedes Teratogenic Congenital Diaphragmatic Hernia and May Contribute to Hypoplastic Lung Morphogenesis Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 571 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Jesudason, N. P. Smith, M. G. Connell, D. G. Spiller, M. R. H. White, D. G. Fernig, and P. D. Losty Peristalsis of airway smooth muscle is developmentally regulated and uncoupled from hypoplastic lung growth Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L559 - L565. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |